Eltrombopag
Eltrombopag is a daily tablet that raises platelet counts by stimulating the bone marrow; it is approved for immune thrombocytopenia and severe aplastic anaemia, and haematologists also use it when low platelets complicate blood cancers and their treatment.
Overview
Eltrombopag is an oral thrombopoietin receptor agonist first approved in the United States in 2008 for chronic immune thrombocytopenia (ITP) that has not responded to steroids, immunoglobulins or splenectomy. Its label also covers thrombocytopenia in hepatitis C to allow interferon treatment and severe aplastic anaemia, a bone marrow failure that sits alongside myelodysplastic syndromes in haematology clinics. It is not approved for chemotherapy-induced thrombocytopenia or for low platelets in leukaemia or myelodysplasia, though it has been studied in both and is used off label. Liver toxicity and a possible increase in marrow fibrosis or blast counts are the main cautions.
A small molecule that binds the transmembrane part of the thrombopoietin receptor (MPL) on megakaryocytes and their precursors, driving them to make platelets.
1.Eltrombopag slips into a pocket on its target.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 2008 | Chronic immune thrombocytopenia with insufficient response to corticosteroids, immunoglobulins or splenectomy · Later extended to thrombocytopenia in chronic hepatitis C and to severe aplastic anaemia |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Eltrombopag" OR ABSTRACT:"Eltrombopag" OR TITLE:"Promacta" OR ABSTRACT:"Promacta" OR TITLE:"Revolade" OR ABSTRACT:"Revolade" OR TITLE:"Eltrombopag Olamine" OR ABSTRACT:"Eltrombopag Olamine" OR TITLE:"SB-497115" OR ABSTRACT:"SB-497115") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Eltrombopag, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentFostamatinib
Shares Thrombocytopenia and the tags gap-fill, supportive-care.
- TreatmentRavulizumab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags gap-fill, supportive-care.
- TreatmentEmapalumab
Shares the tags gap-fill, supportive-care.
- TreatmentPropranolol (Hemangeol)
Shares the tags gap-fill, supportive-care.
- TreatmentCeritinib
Shares Novartis and the tag gap-fill.
- TreatmentCapmatinib
Shares Novartis and the tag gap-fill.
- TargetCD7
Shares Acute myeloid leukaemia and the tag gap-fill.
- TreatmentGlasdegib
Shares Acute myeloid leukaemia and the tag gap-fill.